Gold vs US Dollar

Register for streaming realtime charts, analysis tools, and prices.

Get Started

Home
Investing
Stocks
USA
NASDAQ
TG Therapeutics Inc (TGTX)
TG Therapeutics Inc (TGTX) Financials

TGTX TG Therapeutics Inc

29.3177

0.1777 (0.61%)

18 Jan 2025 - Closed

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-93.017	-155.721	-191.695	-140.187	-70.85	-69.255	-69.203	4.844
Return on Equity (%)	-113.871	-230.361	-381.158	-551.854	-100.143	-92.029	-134.128	11.568
Return on Invested Capital (%)	-145.034	-244.633	-412.893	-399.157	-93.065	-87.387	-101.568	10.833
Operating Margin (%)	-51482.237	-77944.737	-114132.895	-110252.632	-179639.474	-5119.794	-6755.619	10.989
Net Profit Margin (%)	-51482.237	-77944.737	-114132.895	-113730.921	-183803.289	-5204.081	-7121.544	5.423
Book Value Per Share	0.558	0.835	0.258	0.327	3.535	1.582	0.379	0.995
Earnings Per Share	-1.244	-1.495	-1.928	-1.497	-1.904	-2.33	-1.3	0.079
Cash Per Share	0.398	0.716	0.466	0.975	3.773	2.001	0.671	0.579
Working Capital Per Share	0.54	0.825	0.446	0.56	3.573	1.778	0.755	1.646
Operating Profit Per Share	0.002	0.002	0.002	0.001	0.001	0.041	0.017	1.369
EBIT Per Share	-1.244	-1.495	-1.928	-1.497	-1.904	-2.33	-1.3	0.081
EBITDA Per Share	-1.244	-1.495	-1.928	-1.497	-1.904	-2.33	-1.3	0.081
Free Cash Flow Per Share	-1.24	-1.496	-1.928	-1.496	-1.903	-2.33	-1.302	0.078

Liquidity Ratios

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	56.78M	73.14M	83.87M	109.38M	140.58M	143.25M	146.39M	154.42M

Key Stats and Ratios

Year End 31 December 2023	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	145.36M	146.39M	N/A	N/A	N/A	154.42M	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	N/A	-466.333	N/A	N/A	N/A	-13.218	N/A
Net Profit Margin (%)	N/A	N/A	-502.781	N/A	N/A	N/A	-16.868	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	4.54B
Price to Earnings Ratio	363.02
Price to Sales Ratio	19.69
Price to Cash Ratio	49.5
Price to Book Ratio	28.66
Dividend Yield	-

Share Statistics

Shares Outstanding	155.67M
Average Volume (1 week)	3.4M
Average Volume (1 Month)	2.49M
52 Week Change	98.90%
52 Week High	36.84
52 Week Low	12.84

More Ratios Coming Soon!

TG Therapeutics

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions